Tmrw issued a formal correction to its recent press release regarding a new supplement stack launch, clarifying details without altering the company's core business projections.
Tmrw issued a correction to its press release announcing the launch of a clinically dosed supplement alternative, with no material change to the underlying business outlook.
Tmrw has released a corrected version of its announcement concerning the launch of a clinically dosed supplement alternative. The company confirmed that the revisions do not impact the underlying business outlook or the strategic direction of the product rollout.
No, the company stated that the revisions to the press release do not result in any material change to its underlying business outlook.